Keywords: کمپلکس توبروس اسکلروزیس; mammalian target of rapamycin; odontogenic fibroma; tuberous sclerosis complex;
مقالات ISI کمپلکس توبروس اسکلروزیس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کمپلکس توبروس اسکلروزیس; Actin dynamics; Rho GTPases; dendritic spines; postsynapse; Abi-1; Abelson interacting protein 1; Abp1; actin binding protein 1; ACTN4; α-actinin-4; ADF; actin-depolymerizing factor; ADHD; attention deficit/hyperactivity disorder; ADNP; activity-dependen
Keywords: کمپلکس توبروس اسکلروزیس; High frequency oscillations; Fast ripples; Epilepsy; Tuberous sclerosis complex;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Subependymal giant cell astrocytoma; Angiofibromas; Hamartoma;
Keywords: کمپلکس توبروس اسکلروزیس; CT; computed tomography; FDG-PET/CT; fluorodeoxyglucose-positron emission tomography/computed tomography; MRI; magnetic resonance imaging; mTOR; mammalian target of rapamycin; OM; odontogenic myxoma; TS; tuberous sclerosis, also known as Bourneville-Pring
Keywords: کمپلکس توبروس اسکلروزیس; tuberous sclerosis complex; mTOR inhibitors; SEGA; everolimus; hydrocephalus; treatment;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Epilepsy; Register study;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Glomerulocystic kidney;
Keywords: کمپلکس توبروس اسکلروزیس; tuberous sclerosis complex; autism spectrum disorder; autism observational scale for infants; Autism Diagnostic Observation Schedule; infants; toddlers;
Keywords: کمپلکس توبروس اسکلروزیس; IL-1B; interlukins 1-beta; LPS; lipopolysaccharide; ICE; IL-1β converting enzyme; TLE; temporal lobe epilepsy; BBB; blood brain barrier; NMDA; N-methyl-d-aspartate; IL-1R1; interlukin-1 receptor, type 1; TNF-alpha; tumor necrosis factor- alpha; PTZ; pent
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous Sclerosis Complex; Epilepsy; Seizures; Infantile spasms; Cognitive development; Autism spectrum disorder;
Keywords: کمپلکس توبروس اسکلروزیس; Aggression; Challenging behaviour; Self-injury; TSC-associated neuropsychiatric disorders (TAND); Tuberous sclerosis complex;
Keywords: کمپلکس توبروس اسکلروزیس; angiofibromas; fibrous cephalic plaque; hypomelanotic macules; shagreen patch; sirolimus; treatment; tuberous sclerosis complex; ungual fibroma; CC; complete clearance; FAs; facial angiofibromas; FASI; Facial Angiofibroma Severity Index; FCP; fibrous ceph
Keywords: کمپلکس توبروس اسکلروزیس; ASD; autism spectrum disorders; BTBR; BTBR T+Itpr3tf/J mouse strain; cKO; conditional knockout; CNS; central nervous system; CNTNAP2; contactin-associated protein-like 2; DREADD; designer receptors exclusively activated by designer drugs; DSM-5; Diagnosti
Keywords: کمپلکس توبروس اسکلروزیس; tuberous sclerosis complex; TSC; seizures; development disability; prenatal diagnosis; epilepsy;
Keywords: کمپلکس توبروس اسکلروزیس; Ac; acetyl group; AUC; area under the curve; BBB; Blood-brain barrier; BCRP; breast cancer resistance protein; CDK; cyclin-dependent kinase; CLIA; Clinical Laboratory Improvement Amendments; CNS; Central nervous system; CNS-TAP; CNS Targeted Agent Predict
Keywords: کمپلکس توبروس اسکلروزیس; autophagy; FEV1; lymphangioleiomyomatosis; sirolimus; VEGF-D; 6-MWD; 6-min walk distance; AML; angiomyolipoma; Dlco; diffusion coefficient for carbon monoxide; DLT; dose-limiting toxicity; LAM; lymphangioleiomyomatosis; MTD; maximal tolerated dose; NCI; N
Keywords: کمپلکس توبروس اسکلروزیس; Subependymal giant cell astrocytoma; SEGA; Tuberous sclerosis complex; TSC;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Epilepsy; Diffusion tensor imaging; White matter; Autism; Cognitive impairment;
Keywords: کمپلکس توبروس اسکلروزیس; Epidemiology; Cancer; Radiation protection; AT; ataxia telangiectasia; CI; confidence interval; CNS; central nervous system; ERR; excess relative risk; HR; hazard ratio; ICRP; International Commission on Radiological Protection; INWORKS; International Nuc
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Angiomyolipoma; Tuberin; Hamartin; Renal cell carcinoma; Polycystic kidney disease;
Keywords: کمپلکس توبروس اسکلروزیس; EZ; epileptogenic zone; FR; fast ripple; HFOs; high frequency oscillations; ICEEG; intracranial electroencephalography; SOZ; seizure onset zone; TFA; Time-Frequency Analysis; TSC; Tuberous Sclerosis Complex; Tuberous sclerosis complex (TSC); High frequenc
Keywords: کمپلکس توبروس اسکلروزیس; mTOR; mammalian target of rapamycin; EBI; early brain injury; SAH; subarachnoid hemorrhage; SD; Sprague-Dawley; BBB; blood-brain barrier; aSAH; aneurysmal subarachnoid hemorrhage; ICP; increasing intracranial pressure; CBF; cerebral blood flow; PI3K; phos
Keywords: کمپلکس توبروس اسکلروزیس; Transient receptor potential vanilloid 4; Protein kinase C; Protein kinase A; Tuberous sclerosis complex; Epilepsy;
Keywords: کمپلکس توبروس اسکلروزیس; Epilepsy; Seizures; Tuberous Sclerosis Complex; Antiseizure drugs; Ketogenic diet; Vagal nerve stimulator; Resective surgery;
Keywords: کمپلکس توبروس اسکلروزیس; CK; casein kinase; Cvt; cytoplasm-to-vacuole targeting; DRPs; dynamin-related proteins; ER; endoplasmic reticulum; EPCONS; ER-to-peroxisome contact sites; mPTS; membrane peroxisomal targeting signal; MS; mass spectrometry; mTOR; mammalian target of rapamy
Keywords: کمپلکس توبروس اسکلروزیس; ASDs; Autism spectrum disorders; CNV; copy number variant; eIPSC; evoked IPSC; FMRP; fragile X mental retardation protein; FXS; fragile X syndrome; LOH; loss of heterozygosity; LTD; long-term depression; LTP; long-term potentiation; mEPSCs; miniature exci
Keywords: کمپلکس توبروس اسکلروزیس; TSC; tuberous sclerosis complex; MEGSS; magnetoencephalography spike sources; IVEEG; intracranial video EEG; Tuberous sclerosis complex; Magnetoencephalography; Epileptic network; Seizure outcome; Epilepsy surgery; Intractable epilepsy;
Keywords: کمپلکس توبروس اسکلروزیس; Epilepsy; Tuberous sclerosis complex; Adjunctive therapy; Anticonvulsants; LCS
Keywords: کمپلکس توبروس اسکلروزیس; Hamartomatous polyposis; Tuberous sclerosis complex; Histology; Immunohistochemistry; TSC 1 mutation;
Keywords: کمپلکس توبروس اسکلروزیس; attention-deficit–hyperactivity disorder; autism spectrum disorder; seizure; tuberous sclerosis complex
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Subependymal nodules; Susceptibility-weighted imaging; Phase shift; Phase image; Calcification
Keywords: کمپلکس توبروس اسکلروزیس; Dlco; diffusing capacity of the lung for carbon monoxide; GTP; guanosine triphosphate; GTPase; guanosine triphosphatase; LAM; lymphangioleiomyomatosis; mTOR; mechanistic target of rapamycin; Rheb; Ras homolog enriched in brain; TSC; tuberous sclerosis com
Keywords: کمپلکس توبروس اسکلروزیس; tuberous sclerosis complex; white matter; development; human; diffusion imaging; tractography; epilepsy; gender
Keywords: کمپلکس توبروس اسکلروزیس; Neurocutaneous; Neurogenetic; Tuberous sclerosis complex; Subependymal giant cell astrocytoma; Epilepsy; Autism; Mechanistic target of rapamycin (mTOR); Rapamycin;
Keywords: کمپلکس توبروس اسکلروزیس; ICD; International Classification of Diseases; LAM; lymphangioleiomyomatosis; RAMQ; Régie de l'Assurance-Maladie du Québec; TSC; tuberous sclerosis complex;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; TSC1; TSC2; Angiomyolipomas; West syndrome
Keywords: کمپلکس توبروس اسکلروزیس; subependymal giant cell astrocytoma; tuberous sclerosis complex; outcome; surgery; prognostic factor; mTOR inhibitors;
Keywords: کمپلکس توبروس اسکلروزیس; AML; Angiomyolipoma; BSA; Body surface area; MRI; Magnetic resonance imaging; mTOR; Mammalian target of rapamycin; SEGA; Subependymal giant cell astrocytoma; TSC; Tuberous sclerosis complex;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Subependymal giant cell astrocytoma; Rhabdomyoma; Epilepsy
Keywords: کمپلکس توبروس اسکلروزیس; array-based comparative genomic hybridization; cutaneous clear cell myomelanocytic tumor; initiating mutations; mTOR pathway; perivascular epithelioid cell tumor; aCGH; array-based comparative genomic hybridization; MiTF; micro-ophthalmia-associated trans
Keywords: کمپلکس توبروس اسکلروزیس; Aβ; amyloid-β; AD; Alzheimer's disease; ALP; autophagy-lysosome pathway; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ApoER2; apolipoprotein E receptor 2; APP; Aβ precursor protein; BDNF; brain-derived neurotrophic factor; CSF; cere
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Meta-analysis; Epilepsy surgery; Seizure freedom; Outcome;
Keywords: کمپلکس توبروس اسکلروزیس; CFB; Central fibrous body; IUD; Intrauterine death; IVS; Interventricular septum; SENs; Sub-ependymal nodules; TSC; Tuberous sclerosis complex;
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Inflammatory cytokine; Interleukin 17; Epilepsy;
Keywords: کمپلکس توبروس اسکلروزیس; 4E-BP1; eIF4E binding protein 1; 5â²-UTR; 5â²-untranslated region; AMPK; AMP-activated protein kinase; eIF; eukaryotic initiation factor; GCN2; general-control nonderepressible; GEF; guanine nucleotide exchange factor; GSK-3; glycogen synthase kinase-3;
Keywords: کمپلکس توبروس اسکلروزیس; Dendrite; mTOR; Tuberous sclerosis complex; Filamin A; Circuit; Network; Neurogenesis
Keywords: کمپلکس توبروس اسکلروزیس; Tuberous sclerosis complex; Unilateral blinking; Seizure semiology; Epilepsy surgery
Keywords: کمپلکس توبروس اسکلروزیس; Long-term weekly ACTH therapy; West syndrome; Tuberous sclerosis complex; Relapse; Epileptic spasms; Hypsarrhythmia
Dramatic relapse of seizures after everolimus withdrawal
Keywords: کمپلکس توبروس اسکلروزیس; Everolimus; Subependymal giant cell astrocytoma; SEGA; Tuberous sclerosis complex; Epilepsy; mTOR inhibitors;